Listeria infection in patients on anti-TNF treatment: Report of two cases and review of the literature

Journal of Crohn's and Colitis

Volumn 7, Issue 2, 2013, Pages 175-182

  Abreu, Cândida ^a,b   Magro, Fernando ^a,b,c   Vilas Boas, Filipe ^a,b   Lopes, Susana ^a,b   Macedo, Guilherme ^a,b   Sarmento, António ^a,b  

^a HOSPITAL DE SÃO JOÃO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

Anti TNF alpha; Inflammatory bowel disease; Listeria monocytogenes

Indexed keywords

AMPICILLIN; AZATHIOPRINE; C REACTIVE PROTEIN; CIPROFLOXACIN; EFAVIRENZ; EMTRICITABINE; GANCICLOVIR; GENTAMICIN; GLUCOSE; INFLIXIMAB; ISONIAZID; MESALAZINE; METRONIDAZOLE; PREDNISOLONE; STEROID; TENOFOVIR; VALGANCICLOVIR;

ABDOMINAL PAIN; ADULT; AGED; ANTIBIOTIC THERAPY; ANTIVIRAL THERAPY; ARTICLE; BLOODY DIARRHEA; CASE REPORT; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CEREBROSPINAL FLUID CULTURE; CHLAMYDIASIS; CORTICOSTEROID THERAPY; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHEMA; FEMALE; FEVER; GONORRHEA; HEADACHE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INTESTINE MOTILITY; LEUKOCYTE COUNT; LISTERIOSIS; MAINTENANCE THERAPY; MALE; NAUSEA; PANCOLITIS; PRIORITY JOURNAL; RECTUM BIOPSY; REMISSION;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; FEMALE; HIV INFECTIONS; HUMANS; IMMUNOCOMPROMISED HOST; MALE; MENINGITIS, LISTERIA; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84872446029     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2012.04.018     Document Type: Article

References (36)

1. Silva L.C., Ortigosa L.C., Benard G. Anti-TNF-alpha agents in the treatment of immune-mediated inflammatory diseases: mechanisms of action and pitfalls. Immunotherapy 2010 Nov, 2(6):817-833.
2. Culver E.L., Travis S.P. How to manage the infectious risk under anti-TNF in inflammatory bowel disease. Curr Drug Targets Feb 2010, 11(2):198-218.
3. Death toll from listeria outbreak rises to 29 2012, Ref Type: Internet Communication.
4. Nakane A., Minagawa T., Kato K. Endogenous tumor necrosis factor (cachectin) is essential to host resistance against Listeria monocytogenes infection. Infect Immun Oct 1988, 56(10):2563-2569.
5. Bowie V.L., Snella K.A., Gopalachar A.S., Bharadwaj P. Listeria meningitis associated with infliximab. Ann Pharmacother Jan 2004, 38(1):58-61.
6. Izbeki F., Nagy F., Szepes Z., Kiss I., Lonovics J., Molnar T. Severe Listeria meningoencephalitis in an infliximab-treated patient with Crohn's disease. Inflamm Bowel Dis Mar 2008, 14(3):429-431.
7. Kesteman T., Yombi J.C., Gigi J., Durez P. Listeria infections associated with infliximab: case reports. Clin Rheumatol Dec 2007, 26(12):2173-2175.
8. Slifman N.R., Gershon S.K., Lee J.H., Edwards E.T., Braun M.M. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum Feb 2003, 48(2):319-324.
9. Tweezer-Zaks N., Shiloach E., Spivak A., Rapoport M., Novis B., Langevitz P. Listeria monocytogenes sepsis in patients treated with anti-tumor necrosis factor-alpha. Isr Med Assoc J Nov 2003, 5(11):829-830.
10. Dixon W.G., Watson K., Lunt M., Hyrich K.L., Silman A.J., Symmons D.P. Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy: results from the British Society for Rheumatology Biologics Register. Arthritis Rheum Aug 2006, 54(8):2368-2376.
11. Southwick F.S., Purich D.L. Intracellular pathogenesis of listeriosis. N Engl J Med Mar 21, 1996, 334(12):770-776.
12. Dinarello C.A. Anti-cytokine therapeutics and infections. Vaccine Jun 1, 2003, 21(Suppl. 2):S24-S34.
13. Schaible T.F. Important drug warning (Centocor) October 4, 2001, FDA Web site. October 4, 2001. 2012. 10-1-2012. Ref Type: Internet Communication.
14. Nguyen B.Y., Reveille J.D. Rheumatic manifestations associated with HIV in the highly active antiretroviral therapy era. Curr Opin Rheumatol Jul 2009, 21(4):404-410.
15. Cepeda E.J., Williams F.M., Ishimori M.L., Weisman M.H., Reveille J.D. The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease. Ann Rheum Dis May 2008, 67(5):710-712.
16. Beltran B., Nos P., Bastida G., Iborra M., Hoyos M., Ponce J. Safe and effective application of anti-TNF-alpha in a patient infected with HIV and concomitant Crohn's disease. Gut Nov 2006, 55(11):1670-1671.
17. Habib S.F., Hasan M.Z., Salam I. Infliximab therapy for HIV positive Crohn's disease: a case report. J Crohns Colitis Dec 2009, 3(4):302-304.
18. Toruner M., Loftus E.V., Harmsen W.S., Zinsmeister A.R., Orenstein R., Sandborn W.J., et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology Apr 2008, 134(4):929-936.
19. Fidder H., Schnitzler F., Ferrante M., Noman M., Katsanos K., Segaert S., et al. Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study. Gut Apr 2009, 58(4):501-508.
20. Morelli J., Wilson F.A. Does administration of infliximab increase susceptibility to listeriosis?. Am J Gastroenterol Mar 2000, 95(3):841-842.
21. Aparicio A.G., Munoz-Fernandez S., Bonilla G., Miralles A., Cerdeno V., Martin-Mola E. Report of an additional case of anti-tumor necrosis factor therapy and Listeria monocytogenes infection: comment on the letter by Gluck et al. Arthritis Rheum Jun 2003, 48(6):1764-1765.
22. Pagliano P., Attanasio V., Fusco U., Mohamed D.A., Rossi M., Faella F.S. Does etanercept monotherapy enhance the risk of Listeria monocytogenes meningitis?. Ann Rheum Dis Apr 2004, 63(4):462-463.
23. Kelesidis T., Salhotra A., Fleisher J., Uslan D.Z. Listeria endocarditis in a patient with psoriatic arthritis on infliximab: are biologic agents as treatment for inflammatory arthritis increasing the incidence of Listeria infections?. J Infect May 2010, 60(5):386-396.
24. Kamath B.M., Mamula P., Baldassano R.N., Markowitz J.E. Listeria meningitis after treatment with infliximab. J Pediatr Gastroenterol Nutr Apr 2002, 34(4):410-412.
25. Gluck T., Linde H.J., Scholmerich J., Muller-Ladner U., Fiehn C., Bohland P. Anti-tumor necrosis factor therapy and Listeria monocytogenes infection: report of two cases. Arthritis Rheum Aug 2002, 46(8):2255-2257.
26. Joosten A.A., van Olffen G.H., Hageman G. Meningitis due to Listeria monocytogenes as a complication of infliximab therapy. Ned Tijdschr Geneeskd Jul 26, 2003, 147(30):1470-1472.
27. Williams G., Khan A.A., Schweiger F. Listeria meningitis complicating infliximab treatment for Crohn's disease. Can J Infect Dis Med Microbiol Sep 2005, 16(5):289-292.
28. Cabades OF, Vila F.V., Arnal B.M., Polo Sanchez J.A. Lysteria encephalitis associated to infliximab administration. Rev Clin Esp May 2005, 205(5):250.
29. de la Fuente P.B., Marco P.A., Riera M.A., Boadas M.J. Sepsis caused by Listeria monocytogenes related with the use of infliximab. Med Clin (Barc) Mar 19, 2005, 124(10):398.
30. Ramanampamonjy R.M., Laharie D., Bonnefoy B., Vergniol J., Amouretti M. Infliximab therapy in Crohn's disease complicated by Listeria monocytogenes meningoencephalitis. Gastroenterol Clin Biol Jan 2006, 30(1):157-158.
31. Dederichs F., Pinciu F., Gerhard H., Eveld K., Stallmach A. Listeria meningitis in a patient with Crohn's disease-a seldom, but clinically relevant adverse event of therapy with infliximab. Z Gastroenterol Aug 2006, 44(8):657-660.
32. Osuna M.R., Ferrer R.T., Gallego G.R., Ramos L.M., Ynfante F.M., Figueruela L.B. Listeria meningitis as complication of treatment with infliximab in a patient with Crohn's disease. Rev Esp Enferm Dig Jan 2006, 98(1):60-61.
33. Yamamoto M., Takahashi H., Miyamoto C., Ohara M., Suzuki C., Naishiro Y., et al. A case in which the subject was affected by Listeia meningoencephalitis during administration of infliximab for steroid-dependent adult onset Still's disease. Nihon Rinsho Meneki Gakkai Kaishi Jun 2006, 29(3):160-168.
34. Pena-Sagredo J.L., Hernandez M.V., Fernandez-Llanio N., Gimenez-Ubeda E., Munoz-Fernandez S., Ortiz A., et al. Listeria monocytogenes infection in patients with rheumatic diseases on TNF-alpha antagonist therapy: the Spanish Study Group experience. Clin Exp Rheumatol Sep 2008, 26(5):854-859.
35. Ramos J.M., Garcia-Sepulcre M.F., Masia M., Brotons A., Grau M.C., Gutierrez F. Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy. Rev Esp Enferm Dig Oct 2010, 102(10):614-616.
36. Chuang M.H., Singh J., Ashouri N., Katz M.H., Arrieta A.C. Listeria meningitis after infliximab treatment of ulcerative colitis. J Pediatr Gastroenterol Nutr Mar 2010, 50(3):337-339.